Skip to main content
NIH funding notice PA-16-030

Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01)

Closed on January 24, 2018.

Posted
November 3, 2015
Close date
January 24, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,050,611 in first-year total cost, median $525,306.

Most frequent study sections

  1. Kidney, Nutrition, Obesity and Diabetes Study Section[KNOD]1
  2. Nursing and Related Clinical Sciences Study Section[NRCS]1

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. VIRGINIA COMMONWEALTH UNIVERSITY1
Competing awards under PA-16-030 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Metabolomics of Uremic Symptoms in Dialysis Patients1R01NR017399-01A1RHEE, EUGENE P.SHAFI, TARIQMASSACHUSETTS GENERAL HOSPITAL, MA$592,581KNOD
2018Genetic and Epigenetic Regulation of COMT, a Key Moderator of Cognitive Decline1R01NR017221-01A1SWIFT-SCANLAN, THERESAVIRGINIA COMMONWEALTH UNIVERSITY, VA$458,030NRCS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.